Submit Deal

AMGEN VENTURES

Summary

Amgen Ventures is Amgen's corporate venture capital fund, dedicated to providing emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics.

Deals Overview

Total Deals13

Valued Deals13

Total Value£ 2.01 B

Avg. Deal Size£ 155 M

Market Context

Senior Management

Robert Bradway
Chairman and CEO
Philip Tagari
Vice President
Janis Naeve
Managing Director

Sort

26 May 2021|United States|Digital Services

Target: AKILI INTERACTIVE LABS

Bidder: QUAD INVESTMENT MANAGEMENT

17 Service Providers

2 Target | 15 Bidder

24 Dealmakers

9 Target | 15 Bidder

£ 112 M

Value

20 Oct 2021|United States|Risk and Compliance

Target: SAAMA TECHNOLOGIES INC

Bidder: MCKESSON VENTURES

13 Service Providers

2 Target | 11 Bidder

52 Dealmakers

14 Target | 38 Bidder

£ 312 M

Value

20 Dec 2021|United States|Biotechnology

Target: SENTI BIOSCIENCES

Bidder: DYNAMICS SPECIAL PURPOSE CORPORATION

17 Service Providers

3 Target | 14 Bidder

42 Dealmakers

18 Target | 24 Bidder

£ 453 M

Value

29 Jun 2022|United States|Pharmaceuticals

Target: RECODE THERAPEUTICS

Bidder: MPM CAPITAL

6 Service Providers

4 Target | 2 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 163 M

Value

24 Mar 2022|United States|Biotechnology

Target: CELSIUS THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

2 Service Providers

1 Target | 1 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 68 M

Value

20 Jul 2022|United States|Pharmaceuticals

Target: BIGHAT BIOSCIENCES

Bidder: SECTION 32 (S32)

13 Service Providers

3 Target | 10 Bidder

15 Dealmakers

4 Target | 11 Bidder

£ 62 M

Value

20 Sep 2022|Singapore|Biotechnology

Target: IMMUNOSCAPE

Bidder: ANZU PARTNERS

4 Service Providers

1 Target | 3 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 12 M

Value

17 Oct 2022|Canada|Biotechnology

Target: INVERSAGO PHARMA

Bidder: NEW ENTERPRISE ASSOCIATES (NEA)

10 Service Providers

3 Target | 7 Bidder

19 Dealmakers

12 Target | 8 Bidder

£ 62 M

Value

14 Sep 2023|United States|Biotechnology

Target: GENERATE BIOMEDICINES

Bidder: MIRAE ASSET FINANCIAL GROUP

14 Service Providers

1 Target | 13 Bidder

17 Dealmakers

4 Target | 13 Bidder

£ 218 M

Value

04 Dec 2023|United States|Biotechnology

Target: SEISMIC THERAPEUTIC

Bidder: GV (GOOGLE VENTURES)

13 Service Providers

3 Target | 10 Bidder

14 Dealmakers

4 Target | 10 Bidder

£ 95 M

Value

16 Jan 2024|United Kingdom|Software

Target: QUANTINUUM

Bidder: MITSUI & CO

6 Service Providers

3 Target | 3 Bidder

19 Dealmakers

16 Target | 3 Bidder

£ 235 M

Value

13 Feb 2024|United States|Biotechnology

Target: BIOAGE

Bidder: RTW INVESTMENTS

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 134 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy